Coherus Oncology, Inc. (CHRS)
 NASDAQ: CHRS · Real-Time Price · USD
 1.700
 -0.030 (-1.73%)
  At close: Oct 30, 2025, 4:00 PM EDT
1.740
 +0.040 (2.35%)
  After-hours: Oct 30, 2025, 7:56 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $197.59 million as of October 30, 2025. Its market cap has increased by 82.61% in one year.
Market Cap 
 197.59M
Enterprise Value 
 978.37K
1-Year Change 
 82.61%
Ranking 
 Category 
 Stock Price 
$1.70
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $197.59M, a decrease of -51.12%. That is a compound annual growth rate of -6.31%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 201.10M | 26.48% | 
| Dec 31, 2024 | 159.00M | -57.12% | 
| Dec 29, 2023 | 370.80M | -39.81% | 
| Dec 30, 2022 | 616.00M | -49.73% | 
| Dec 31, 2021 | 1.23B | -2.13% | 
| Dec 31, 2020 | 1.25B | -0.83% | 
| Dec 31, 2019 | 1.26B | 105.12% | 
| Dec 31, 2018 | 615.60M | 20.73% | 
| Dec 29, 2017 | 509.90M | -58.50% | 
| Dec 30, 2016 | 1.23B | 37.60% | 
| Dec 31, 2015 | 893.00M | 64.52% | 
| Dec 31, 2014 | 542.80M | 34.29% | 
| Nov 6, 2014 | 404.20M | - | 
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 755.74B | 
| Johnson & Johnson | 453.43B | 
| AbbVie | 404.61B | 
| UnitedHealth Group | 314.45B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 217.78B |